Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease.

Journal of the neurological sciences - 31 Jan 2007

Lin Juei-Jueng, Yueh Kuo-Chu, Lin Shinn-Zong, Harn Horng-Jyh, Liu Jung-Tung

Abstract excerpt

There was increasing evidence suggesting that angiotensin I-converting enzyme may play an important role in the pathogenesis of PD. Our former study has shown that angiotensin I-converting enzyme gene (ACE) may confer a susceptibility for the risk of Parkinson's disease (PD). Meanwhile, recent studies have emphasized that genetic factors may involve in the occurrence of the adverse effects of chronic L-dopa...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Antiparkinson Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Dyskinesia, Drug-Induced

Share to Homozygote

Share to Levodopa

Share to Parkinson Disease

Share to Peptidyl-Dipeptidase A

Share to Predictive Value of Tests

Source

Identifiers

PMID: 17196621
DOI: 10.1016/j.jns.2006.10.018

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease.PMID 17196621Read ↗

Genetic polymorphism of Angiotensin-Converting Enzyme is not associated with the development of Parkinson's disease and of L-dopa-induced adverse effects.Semantic proximity Read ↗

The angiotensin-converting enzyme (ACE) I/D polymorphism in Parkinson's disease.Semantic proximity Read ↗

Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson's disease.Semantic proximity Read ↗

<scp>l</scp>-Dopa-induced adverse effects in PD and dopamine transporter gene polymorphismSemantic proximity Read ↗

Role of ADH2 and ALDH2 gene polymorphisms in the development of Parkinson's disease in a Chinese population.Semantic proximity Read ↗

The insertion/deletion polymorphism in the angiotensin-converting enzyme and susceptibility to schizophrenia or Parkinson's disease: A meta-analysis.Semantic proximity Read ↗

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease.Semantic proximity Read ↗

[ApoE polymorphisms and dopaminergic replacement therapy in Parkinson's disease].Semantic proximity Read ↗

Genetic susceptibility of impulse control and related behavior in Parkinson's disease.Semantic proximity Read ↗

DRD4 Gene polymorphism and impulse control disorder induced by dopamine agonists in Parkinson's disease.Semantic proximity Read ↗

Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.Semantic proximity Read ↗

Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.